Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults.
Date
2007Author
ayitenkore, K
Omosa-Manyonyi, G
Bwayo, J
Karita, E
Jaoko, WG
Schmidt, C
Gilmour, J
Boaz, M
Than, S
Graham, B
Type
PresentationLanguage
enMetadata
Show full item recordCitation
ayitenkore K, Omosa-Manyonyi G, Bwayo J, Karita E, Jaoko WG, Schmidt C, Gilmour J, Boaz M, Than S & Graham B (2007) Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults. CROI, Los Angeles, USAPublisher
University of Nairobi School of Medicine